The prospective trial to validate the superior efficacy of sequential therapy to standard therapy in Helicobacter pylori eradicatio
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0000014
- Lead Sponsor
- Daegu-Kyungpook Gastrointestinal Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 348
1) Ages between 18 and 85
2) Peptic ulcer(active or inactive) in endoscopy and positive for rapid urease test
3) No peptic ulcer in endoscopy but positive for rapid urease test, who want to eradicate the H.pylori
4) Participants who agree to participate in this study after informed consent
1) Patients who refused to participate in this study
2) Paticipants with a history of treatment for H.pylori
3) Use of proton pump inhibitor, antibiotics, H2-receptor antagonists, or bismuth in the previous 2 weeks
4) Concomitant use of anticoagulants, aspirin or steroids
5) History of gastric resection including endoscopic mucosal resection
6) Combined severe cardiovascular, pulmonary or endocrine disorders
7) Serious hepatic or renal dysfunction
8) hematologic disorders
9) Any kinds of malignant diseases
10) pregnancy or lactation, women who were not willing to practice acceptable contraception
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method